Cargando…
Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy
BACKGROUND: Triple negative breast cancer encompasses several biological entities with different outcomes and is a priority to identify which patients require more treatment to reduce the risk of recurrence and which patients need less treatment. PATIENTS AND METHODS: Among the 210 women with first...
Autores principales: | Montagna, Emilia, Cancello, Giuseppe, Pagan, Eleonora, Bagnardi, Vincenzo, Munzone, Elisabetta, Dellapasqua, Silvia, Viale, Giuseppe, Mazzarol, Giovanni, Veronesi, Paolo, Galimberti, Viviana, Santomauro, Giorgia, Colleoni, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424227/ https://www.ncbi.nlm.nih.gov/pubmed/32795829 http://dx.doi.org/10.1016/j.breast.2020.07.003 |
Ejemplares similares
-
Systematic review and meta-analysis of post-progression outcomes in ER+/HER2− metastatic breast cancer after CDK4/6 inhibitors within randomized clinical trials
por: Munzone, E., et al.
Publicado: (2021) -
Pegylated Liposomal Doxorubicin (Caelyx(®)) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial
por: Dellapasqua, Silvia, et al.
Publicado: (2021) -
Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines
por: Munzone, Elisabetta, et al.
Publicado: (2019) -
Management of breast cancer patients during the peak of the COVID 19 pandemic
por: Montagna, E., et al.
Publicado: (2021) -
Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis
por: Bianco, Nadia, et al.
Publicado: (2021)